LGWCOUWMTAQMQT-QCBHMXSDSA-N
- $117 - $418
- Product name: LGWCOUWMTAQMQT-QCBHMXSDSA-N
- CAS: 196493-76-2
- MF: C18H32O6
- MW: 344.44
- EINECS:
- MDL Number:
- Synonyms:LGWCOUWMTAQMQT-QCBHMXSDSA-N;2H-Pyran-3-pentanoic acid, tetrahydro-4,6-dihydroxy-2-[(1E,3S)-3-hydroxy-1-octen-1-yl]-, (2R,3S,4S)-
3 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 25μg
- 50μg
- 100μg
- ManufacturerCayman Chemical
- Product number10006330
- Product description2,3-dinor Thromboxane B1 ≥98%
- Packaging25μg
- Price$117
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number10006330
- Product description2,3-dinor Thromboxane B1 ≥98%
- Packaging50μg
- Price$222
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number10006330
- Product description2,3-dinor Thromboxane B1 ≥98%
- Packaging100μg
- Price$418
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Cayman Chemical | 10006330 | 2,3-dinor Thromboxane B1 ≥98% | 25μg | $117 | 2024-03-01 | Buy |
Cayman Chemical | 10006330 | 2,3-dinor Thromboxane B1 ≥98% | 50μg | $222 | 2024-03-01 | Buy |
Cayman Chemical | 10006330 | 2,3-dinor Thromboxane B1 ≥98% | 100μg | $418 | 2024-03-01 | Buy |
Properties
Boiling point :559.6±50.0 °C(Predicted)
Density :1.189±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: 50 mg/ml; DMSO: 20 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): .15 mg/ml
pka :4.76±0.10(Predicted)
Density :1.189±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: 50 mg/ml; DMSO: 20 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): .15 mg/ml
pka :4.76±0.10(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|